Directory
>
Sherri Van Everen
Sherri Van Everen
Vice President, Ophthalmology Clinical Development | REGENXBIO
San Francisco, California, United States
Sherri Van Everen
Summary
Sherri Van Everen is an accomplished executive in the biotechnology sector, currently serving as Vice President of Ophthalmology Clinical Development at REGENXBIO Inc. With over two decades of experience, she has held various leadership roles in clinical development, medical affairs, and outcomes research. Sherri's educational background includes a Doctor of Pharmacy from The University of Texas at Austin and a Bachelor's in Biomedical Science from Texas A&M University. Her career spans notable organizations such as Genentech and Eli Lilly, where she has significantly contributed to drug development and clinical research initiatives. In addition to her corporate roles, Sherri is also a member of the Board of Directors at the Jack McGovern Coats Disease Foundation, showcasing her commitment to advancing healthcare beyond her professional obligations. Her expertise encompasses a wide range of areas, including immunology and oncology, making her a well-rounded leader in her field.
Sherri Van Everen
Work Experience
Vice President, Ophthalmology Clinical Development at
REGENXBIO
November 2018 - Present
Vice President Medical Affairs at
REGENXBIO
July 2016 - Present
Member Board of Directors at
Jack Mcgovern Coats Disease Foundation
January 2016 - Present
Executive Director, Scientific Collaborations at
Adverum Biotechnologies
October 2014 - December 2015
Principal Medical Science Liaison at
Genentech Foundation
March 2012 - October 2014
Senior Medical Science Liaison at
Genentech Foundation
January 2006 - February 2012
Health Economist at
Genentech Foundation
January 2005 - January 2006
Outcomes Research Liaison at
Eli Lilly and Company
January 2001 - January 2005
Assistant Professor- School of Pharmacy at
Northeastern University Holdings LLC
January 1999 - January 2000
Sherri Van Everen
Education
The University of Texas at Austin, Doctor Of Pharmacy (Pharmd)
January 1995 - January 1999
January 1990 - January 1994
Frequently Asked Questions about Sherri Van Everen
What is Sherri Van Everen email address?
Sherri Van Everen's primary email address is **********@regenxbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sherri Van Everen work for?
Sherri Van Everen is a Vice President, Ophthalmology Clinical Development at REGENXBIO, a company specializing in Commercial physical research.
Where Sherri Van Everen graduated from?
Sherri Van Everen holds a degree in Pharmacy from The University of Texas at Austin.
How can I directly contact Sherri Van Everen?
To contact Sherri Van Everen directly, you can use the email address **********@regenxbio.com. Complete contact information is available upon registration with Muraena.
Who is Sherri Van Everen?
Sherri Van Everen is an accomplished executive in the biotechnology sector, currently serving as Vice President of Ophthalmology Clinical Development at REGENXBIO Inc. With over two decades of experience, she has held various leadership roles in clinical development, medical affairs, and outcomes research. Sherri's educational background includes a Doctor of Pharmacy from The University of Texas at Austin and a Bachelor's in Biomedical Science from Texas A&M University. Her career spans notable organizations such as Genentech and Eli Lilly, where she has significantly contributed to drug development and clinical research initiatives. In addition to her corporate roles, Sherri is also a member of the Board of Directors at the Jack McGovern Coats Disease Foundation, showcasing her commitment to advancing healthcare beyond her professional obligations. Her expertise encompasses a wide range of areas, including immunology and oncology, making her a well-rounded leader in her field.
Sherri`s contact details
**********@regenxbio.com
****************@gene.com
Colleagues
Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases
Chief Medical Officer
Executive Director, Global Product and Market Planning
Executive Director Drug Delivery & Training
Sr Vice President, Quality
Senior Vice President, Global Program Management & Alliance Management
Vice President, Medical Affairs
Chief Communications & People Officer
VP, Nonclinical Development
Executive Director Clinical Operations